Noemi Arrighetti
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- MicroRNA in disease regulation 5
-
- RNA Interference and Gene Delivery 6
- Protein Degradation and Inhibitors 5
- Histone Deacetylase Inhibitors Research 5
- Ubiquitin and proteasome pathways 3
- Circular RNAs in diseases 3
- Extracellular vesicles in disease 2
- Co-authors
- Ennio TasciottiClaudia CorboMichael EvangelopoulosJonathan O. MartinezRoberto MolinaroAlessandro ParodiManuela SushnithaNadia Zaffaroni
- Journals
- Biochemical Pharmacology (3 papers)Frontiers in Cell and Developmental Biology (2 papers)Current Medicinal Chemistry (2 papers)Cancer Letters (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- ItalyUnited StatesJapan
In The Last Decade
Noemi Arrighetti
25 papers receiving 782 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 200
- Biomaterials 128
- Molecular Biology 548
- Oncology 124
- Biomedical Engineering 187
Countries citing papers authored by Noemi Arrighetti
This map shows the geographic impact of Noemi Arrighetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noemi Arrighetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noemi Arrighetti more than expected).
Fields of papers citing papers by Noemi Arrighetti
This network shows the impact of papers produced by Noemi Arrighetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noemi Arrighetti. The network helps show where Noemi Arrighetti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Noemi Arrighetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 16 | |
| 3 | 2023 | 10 | |
| 4 | 2022 | 10 | |
| 5 | 2022 | 8 | |
| 6 | 2021 | 12 | |
| 7 | 2021 | 10 | |
| 8 | 2020 | 19 | |
| 9 | 2020 | 11 | |
| 10 | 2019 | 74 | |
| 11 | 2017 | 218 | |
| 12 | 2017 | 14 | |
| 13 | 2017 | 79 | |
| 14 | 2016 | 39 | |
| 15 | 2014 | 26 | |
| 16 | 2014 | 24 | |
| 17 | 2014 | 4 | |
| 18 | 2014 | 13 | |
| 19 | 2013 | 29 | |
| 20 | 2013 | 15 |
About Noemi Arrighetti
Noemi Arrighetti is a scholar working on Cancer Research, Molecular Biology, Biomaterials, Pathology and Forensic Medicine and Molecular Medicine, having authored 26 papers that have together received 790 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (6 papers), MicroRNA in disease regulation (5 papers), Protein Degradation and Inhibitors (5 papers), Histone Deacetylase Inhibitors Research (5 papers), Cancer Mechanisms and Therapy (4 papers), Ubiquitin and proteasome pathways (3 papers), Circular RNAs in diseases (3 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Cancer Research (200 citations), Biomaterials (128 citations), Molecular Biology (548 citations), Oncology (124 citations) and Biomedical Engineering (187 citations). Noemi Arrighetti has collaborated with scholars based in Italy, United States and Japan. Frequent co-authors include Ennio Tasciotti, Claudia Corbo, Michael Evangelopoulos, Jonathan O. Martinez, Roberto Molinaro, Alessandro Parodi, Manuela Sushnitha, Nadia Zaffaroni, Giovanni Luca Beretta and Laura Gatti. Their work appears in journals such as Biochemical Pharmacology, Frontiers in Cell and Developmental Biology, Current Medicinal Chemistry, Cancer Letters and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.